95 related articles for article (PubMed ID: 2043174)
1. Vaccinium myrtillus anthocyanosides pharmacokinetics in rats.
Morazzoni P; Livio S; Scilingo A; Malandrino S
Arzneimittelforschung; 1991 Feb; 41(2):128-31. PubMed ID: 2043174
[TBL] [Abstract][Full Text] [Related]
2. Studies on Vaccinium myrtillus anthocyanosides. II. Aspects of anthocyanins pharmacokinetics in the rat.
Lietti A; Forni G
Arzneimittelforschung; 1976; 26(5):832-5. PubMed ID: 989354
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability and tissue distribution of anthocyanins in bilberry (Vaccinium myrtillus L.) extract in rats.
Ichiyanagi T; Shida Y; Rahman MM; Hatano Y; Konishi T
J Agric Food Chem; 2006 Sep; 54(18):6578-87. PubMed ID: 16939312
[TBL] [Abstract][Full Text] [Related]
4. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
5. Ingested delphinidin-3-rutinoside is primarily excreted to urine as the intact form and to bile as the methylated form in rats.
Matsumoto H; Ichiyanagi T; Iida H; Ito K; Tsuda T; Hirayama M; Konishi T
J Agric Food Chem; 2006 Jan; 54(2):578-82. PubMed ID: 16417324
[TBL] [Abstract][Full Text] [Related]
6. Preliminary pharmacokinetics of a new pyridopyrimidine derivative.
Pérez MJ; Roch MJ; Ochoa MC
Arzneimittelforschung; 1991 Jun; 41(6):640-4. PubMed ID: 1930354
[TBL] [Abstract][Full Text] [Related]
7. Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity.
Lietti A; Cristoni A; Picci M
Arzneimittelforschung; 1976; 26(5):829-32. PubMed ID: 9100
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
9. The disposition and pharmacokinetics of ketoconazole in the rat.
Remmel RP; Amoh K; Abdel-Monem MM
Drug Metab Dispos; 1987; 15(6):735-9. PubMed ID: 2893696
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
[TBL] [Abstract][Full Text] [Related]
12. [The pharmacokinetics of 14C-zolimidine in rats].
Schraven E; Trottnow D
Arzneimittelforschung; 1976 Feb; 26(2):213-8. PubMed ID: 947201
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
Zhong DF; Li K; Xu JH; Du Y; Zhang YF
Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
[TBL] [Abstract][Full Text] [Related]
17. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study on a new antiischaemic agent (BRLP-42).
Csárdi A; Pátfalusi M; Mészáros S; Vereczkey L
Acta Physiol Hung; 1994; 82(4):321-6. PubMed ID: 7785441
[TBL] [Abstract][Full Text] [Related]
19. Hepatic and intestinal first-pass effects of oltipraz in rats.
Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
